Astellas Pharma and Yaskawa Electric Corporation are setting off on a joint venture to help streamline the infamously tricky process of cell therapy manufacturing. Astellas and Yaskawa have ...

A trade organisation representing pharma manufacturers in Europe has said plans to restrict the use of fluorinated substances known as PFAS could make manufacturing “grind to a halt” and ...